APA (7th ed.) Citation

Eustes, A. S., Kumar, M. K. P., Peterson, J. A., Mast, A. E., Lentz, S. R., & Dayal, S. (2025). Elevated tissue factor pathway inhibitor delays thrombin generation in COVID-19 but is not associated with clinical outcomes. Elsevier.

Chicago Style (17th ed.) Citation

Eustes, Alicia S., Meena Kumari Palani Kumar, Julie A. Peterson, Alan E. Mast, Steven R. Lentz, and Sanjana Dayal. Elevated Tissue Factor Pathway Inhibitor Delays Thrombin Generation in COVID-19 but Is Not Associated with Clinical Outcomes. Elsevier, 2025.

MLA (9th ed.) Citation

Eustes, Alicia S., et al. Elevated Tissue Factor Pathway Inhibitor Delays Thrombin Generation in COVID-19 but Is Not Associated with Clinical Outcomes. Elsevier, 2025.